SS Innovations International (NASDAQ:SSII) Shares Down 6.7% - Should You Sell?

Key Points

• SSII shares fell 6.7% to about $2.78 in mid-day trading, with volume down 90% from the average session level.
• Analyst sentiment remains cautious: MarketBeat reports an average “Sell” rating from one analyst, despite a consensus price target of $7.00; another firm upgraded the stock to “Hold.”
• The company reported a quarterly loss of $0.01 per share, negative net margin and return on equity, while CEO Srivastava Sudhir sold 33,333 shares at an average price of $3.00.

SS Innovations International, Inc. (NASDAQ:SSII - Get Free Report) shares dropped 6.7% during mid-day trading on Thursday. The stock traded as low as $2.80 and last traded at $2.7790. Approximately 7,110 shares traded hands during mid-day trading, a decline of 90% from the average session volume of 70,610 shares. The stock had previously closed at $2.98.

Wall Street Analysts Forecast Growth

SSII has been the topic of a number of recent research reports. Loop Capital set a $7.00 target price on shares of SS Innovations International in a research note on Wednesday, June 3rd. Weiss Ratings reiterated a "sell (e+)" rating on shares of SS Innovations International in a research note on Friday, July 17th. Finally, Wall Street Zen upgraded shares of SS Innovations International from a "sell" rating to a "hold" rating in a report on Sunday, June 28th. One investment analyst has rated the stock with a Sell rating, According to MarketBeat, SS Innovations International presently has an average rating of "Sell" and a consensus price target of $7.00.

SS Innovations International Price Performance

The company has a market capitalization of $568.28 million, a price-to-earnings ratio of -47.27 and a beta of -1.94. The stock has a 50 day simple moving average of $3.49 and a two-hundred day simple moving average of $3.89.

SS Innovations International (NASDAQ:SSII - Get Free Report) last released its quarterly earnings data on Thursday, August 13th. The company reported ($0.01) earnings per share (EPS) for the quarter. SS Innovations International had a negative return on equity of 26.77% and a negative net margin of 23.73%.The business had revenue of $13.94 million for the quarter.

Insider Buying and Selling

In other SS Innovations International news, CEO Srivastava Sudhir sold 33,333 shares of the stock in a transaction that occurred on Friday, September 4th. The shares were sold at an average price of $3.00, for a total value of $99,999.00. Following the transaction, the chief executive officer directly owned 108,520,928 shares in the company, valued at $325,562,784. This represents a 0.03% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the stock. Eversept Partners LP grew its position in shares of SS Innovations International by 46.2% in the 1st quarter. Eversept Partners LP now owns 110,157 shares of the company's stock valued at $551,000 after buying an additional 34,799 shares during the last quarter. Inspire Investing LLC lifted its position in SS Innovations International by 26.4% in the first quarter. Inspire Investing LLC now owns 104,624 shares of the company's stock valued at $523,000 after acquiring an additional 21,851 shares during the last quarter. Finally, IFC & Insurance Marketing Inc. lifted its position in SS Innovations International by 47.7% in the first quarter. IFC & Insurance Marketing Inc. now owns 16,730 shares of the company's stock valued at $84,000 after acquiring an additional 5,400 shares during the last quarter.

SS Innovations International Company Profile

SS Innovations International, Inc is a medical technology company focused on developing, manufacturing and commercializing robotic-assisted surgical systems. Through its operating business in India, the company offers the SSi Mantra robotic surgery platform, which is designed to support minimally invasive procedures across multiple surgical specialties.

The company's product portfolio includes the SSi Mantra system, robotic instruments and related accessories, as well as surgical training, installation, maintenance and support services.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.